Cargando…
Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
Diabetes is well established as a chronic disease with a high health burden due to mortality or morbidity from the final outcomes of vascular complications. An increased duration of hyperglycemia is associated with abnormal metabolism. Advanced glycation end products (AGEs) are nonenzymatic glycated...
Autores principales: | Lee, Jeongmin, Yun, Jae-Seung, Ko, Seung-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370094/ https://www.ncbi.nlm.nih.gov/pubmed/35956261 http://dx.doi.org/10.3390/nu14153086 |
Ejemplares similares
-
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
por: Rhee, Sang Youl, et al.
Publicado: (2018) -
Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014) -
Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011) -
Controlling the receptor for advanced glycation end‐products to conquer diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2012) -
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
por: Guerin-Dubourg, Alexis, et al.
Publicado: (2017)